Need extra support quickly? We are working with clients around the world right now to help them tackle new challenges from COVID-19.  

How can we help you? Learn More >

Dawn Sherman

Chief Executive Officer and Board Member

Dawn brings a wealth of strategic leadership experience to ProPharma Group. She has worked extensively within the healthcare industry, holding roles such as President, COO, and Global Managing Director for several global healthcare companies.

Prior to becoming CEO of ProPharma Group, Dawn was President of EnvisionRxOptions, a national, full-service pharmacy benefit management company. Dawn was responsible for EnvisionRx, MedTrakRx, EnvisionPharmacies, Envision Savings, and LakerSoftware, as well as several functional areas such as strategy, product development, pricing, client analytics, IT, manufacturer and provider relations, marketing, and customer service operations. Dawn also led all integration efforts with Rite Aid since the acquisition of EnvisionRxOptions by Rite Aid in June 2015.

Prior to joining EnvisionRxOptions, Dawn served as Chief Operating Officer (COO) for Teva Pharmaceuticals Europe B.V., where she had oversight of commercial operations across 36 countries as well as global responsibility for patient solutions. Dawn’s broad focus included strategy and innovation for patient support, commercial effectiveness, market access, business insights and intelligence, and government affairs. Additionally, Dawn had responsibility for corporate communications and driving organizational efficiency and effectiveness.

Before joining Teva, Dawn was Chief Operating Officer of Medco International, B.V., where she focused on delivering innovative, integrated clinical services to improve efficiency across the European healthcare system. Before relocating to the Netherlands, Dawn held other roles during her tenure with Medco Health Solutions, Inc., such as Senior Vice President and Chief Operating Officer for Medco’s international strategy and operations, where she led activities related to integrating and operationalizing international business opportunities within Medco.

Prior to Medco, Dawn was Global Managing Director for Hay Group Insight, Hay Group’s survey research division. In this role, she worked with executive management teams and board members from Fortune 100 companies in a wide spectrum of industries with a focus on improving organizational and operational effectiveness.

Dawn completed her undergraduate work at Miami University with degrees in Psychology and Sociology and received her master’s degree in Sociology from New York University.

Company Blog

April 1, 2020
COVID-19 Pandemic in the EU: Fraudulent Medicines, Test Kit Shortage,…
The COVID-19 pandemic is creating many new challenges for our industry around the world.… Read More
March 31, 2020
Ten Tips for Conducting Successful Virtual FDA Meetings in the…
Ten tips for Sponsors now facing virtual FDA meetings rather than face-to-face interactions, and how to… Read More
March 25, 2020
Health Authorities’ Information on the COVID-19 Pandemic Throughout Europe, Part…
How is COVID-19 affecting clinical trials across Europe? Hanneke Dominicus provides more information on… Read More
More Articles

UPCOMING Events

All Events
Contact Us